Études post-AMM : apport dans la réinscription des produits
Thérapie, 64 3 (2009) 203-207
Published online: 2009-08-13
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Can requests for real-world evidence by the French HTA body be planned? An exhaustive retrospective case–control study of medicinal products appraisals from 2016 to 2021
Judith Fernandez, Céleste Babin, Camille Thomassin, Floriane Pelon, Sophie Kelley, Pierre Cochat, Margaret Galbraith, Driss Berdaï, Antoine Pariente, Francesco Salvo and Antoine VanierInternational Journal of Technology Assessment in Health Care 40 (1) (2024)
https://doi.org/10.1017/S0266462324000291
Use of relative effectiveness information in reimbursement and pricing decisions in Europe
Floortje van Nooten and J Jaime CaroJournal of Comparative Effectiveness Research 2 (1) 33 (2013)
https://doi.org/10.2217/cer.12.71
Post-registration studies for the evaluation of antihypertensive drugs
Thomas Hedner, Krzysztof Narkiewicz and Sverre KjeldsenBlood Pressure 20 (sup2) 3 (2011)
https://doi.org/10.3109/08037051.2011.631283
Optimiser la réalisation et l’utilisation des études post-inscription
Thomas Borel, Chrystel Jouan-Flahault, Aude Alfonsi, et al.Therapies 66 (6) 469 (2011)
https://doi.org/10.2515/therapie/2011065